In esophageal squamous cell carcinoma and breast cancer, Numb overexpression suppresses tumor cell growth and epithelial-mesenchymal transition (EMT) by antagonizing Notch signaling, and loss of Numb expression is associated with poor prognosis [11, 12]. The gene discussed is NUMB; the disease is breast carcinoma.